Daratumumab, ixazomib and pomalidomide are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications.
- Daratumumab (Darzalex®) is a CD38-directed antibody and is indicated for the treatment of multiple myeloma.
- Ixazomib (Ninlaro®) is a proteasome inhibitor and is indicated for the treatment of multiple myeloma.
- Pomalidomide (Imnovid®) is a thalidomide analogue and is indicated for the treatment of multiple myeloma.
